Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 4, 2006
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatmentsDaniel T Barratt, Janet K Coller, Andrew A Somogyi
Clinical Pharmacology and Therapeutics|March 7, 2007
Pharmacogenetics of opioidsAndrew A Somogyi, Daniel T Barratt, Janet K Coller
Anaesthesia and Intensive Care|February 3, 2022
New pharmacological perspectives and therapeutic options for opioids: Differences matterAndrew A Somogyi, Stefan T Musolino, Daniel T Barratt
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 11, 2015
Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinibMuhammad Suleman Khan, Daniel T Barratt, Andrew A Somogyi
The Pharmacogenomics Journal|June 1, 2024
Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effectsDaniel T Barratt, Pål Klepstad, Ola Dale, et al.
Pain Medicine (Malden, Mass.)|May 20, 2021
Innate Immune and Neuronal Genetic Markers Are Highly Predictive of Postoperative Pain and Morphine Patient-Controlled Analgesia Requirements in Indian but Not Chinese or Malay Hysterectomy PatientsDaniel T Barratt, Alex T Sia, Ene-Choo Tan, et al.
Plos One|September 3, 2015
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal FentanylDaniel T Barratt, Pål Klepstad, Ola Dale, et al.
Pharmacogenomics|June 24, 2014
Pharmacogenomics of methadone maintenance treatmentAndrew A Somogyi, Daniel T Barratt, Robert L Ali, et al.
Journal of Pharmaceutical Sciences|June 27, 2021
Instability of Efavirenz Metabolites Identified During Method Development and ValidationNatália Bordin Andriguetti, Daniel T Barratt, Joseph Tucci, et al.
Frontiers in Pharmacology|March 11, 2020
No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Pageof 3